Events

Recall of BARD MAGNUM CORE TISSUE BIOPSY NEEDLE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BARD CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    53553
  • Event Risk Class
    I
  • Event Initiated Date
    2013-05-16
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Bard peripheral vascular (bpv) has confirmed that some devices from a specific lot (rewe1689) of product code mn1410 may contain an incorrect (longer) needle length than the size stated on the label. a small number of needles from the lot number specified which should be 10cm were instead 13cm.

Device

BARD MAGNUM CORE TISSUE BIOPSY NEEDLE
  • Model / Serial
    Model Catalog: MN1410 (Lot serial: REWE1689)
  • Product Description
    BARD MAGNUM BIOPSY NEEDLE
  • Manufacturer
    BARD CANADA INC.

Manufacturer

BARD CANADA INC.